Laminate Leadership

Tammy began her career in medical devices as an engineer for Valtech (now a part of Edwards Life Science), which developed solutions for mitral valve repair. Soon after leaving Valtech she pursued her own device ideas and eventually founded Laminate Medical with Dr. Eyal Orion in 2012 to help surgeons make better functioning fistulas. She led the engineering and design efforts in the early days of the company to create VasQ, Laminate’s flagship product. Since then she has raised 10’s of millions of dollars from a diverse array of investors to build a global team that is bringing VasQ to markets around the world. She has also continued the company’s investment in new product development to improve fistula function in parallel with efforts to gain VasQ regulatory clearance in North America and Asia-Pacific.

Anthony brings over a decade of experience in commercializing medical devices, primarily in the vascular access market. After receiving his PhD in Bioenigineering from the University of Washington, Anthony worked as a product specialist at Gore navigating the VIABAHN™ Stent Graft through the final stages of the REVISE study, FDA clearance and initial market launch of the new dialysis access indication. He also worked at St. Jude Medical (now Abbott) to develop the launch strategy for MultiPoint Pacing for their Cardiac Resynchronization Therapy devices. He transitioned back to vascular access with TVA Medical to help gain FDA clearance and develop the market for the endovascular fistula (endoAVF) creation. He stayed on at Becton Dickinson for a year after TVA’s acquisition to help launch endoAVF into the U.S. market and train both the internal team as well as physicians on the device and new procedure. He joined Laminate to continue his work on improving vascular access for dialysis patients by bringing VasQ as well as other innovations in the company’s pipeline to market.

Galit joined the Laminate team in 2024, bringing with her over 20 years of extensive experience in managing clinical activities. Ms. Itzhaki has led clinical studies resulting in CE and FDA approvals, including large scale global multi-center studies in Europe and the US. Before joining Laminate, Galit served as VP Clinical Affairs at Perflow Medical, Executive Clinical Director at Nutrinia, and Clinical Director at OticPharma and NLT. Prior to NLT, she held a variety of positions including Clinical Operations Manager at Dune Medical Devices, Clinical Research Manager at Cato Research Israel, and Pharmaceutical Research Fellow at TEVA Pharmaceuticals Industries. Ms. Itzhaki holds a B.Sc. in Pharmacy from the School of Pharmacy, Faculty of Medicine, at the Hebrew University of Jerusalem, Israel.

Ran started his career in the medical device industry in 2010 as a Manufacturing Engineer at GE Healthcare, after 4 years in a large Telecommunications Company. In GE Healthcare, Ran led manufacturing engineering and product controllership activities for VersaMed Medical Systems (portable life-support ventilators), including distributed production facilities, NPI, design transfer, design changes, processes and tool qualifications, and information system implementation. Ran joined Laminate Medical Technologies in 2015. As VP Operations, he oversees the VasQ Engineering, In-house and Subcontractor Manufacturing, and Supply Chain Management (MRP, Procurement, and Sales Operations). Under Ran’s production management, the company’s operational capabilities have matured from prototype to serial manufacturing in support of growing utilization of VasQ globally. Ran holds Bacherlor’s degree in Industrial Engineering and an MBA.

Orit is a veteran of the Israeli medical device industry with 25 years of experience holding senior management positions in Clinical & Regulatory and Research & Development. She has a Ph.D. and Master’s degree in Biomedical Engineering, with a Bachelor’s degree in Mechanical Engineering, all from Tel Aviv University, Israel. Orit has vast experience in designing and executing large multicenter international clinical studies as well as smaller First in Human clinical studies, both in the pre-market and post-market settings. She has extensive background of successful regulatory submissions for 510k, IDE, PMA, and CE marked medical devices in various disciplines. Being part of Laminate since the early days, Orit designed the clinical strategy and clinical protocols from the First-In-Human Study through the FDA Pivotal Study as well as achieved CE mark approval for VasQ and FDA IDE approval for the Pivotal Study.

Kent brings more than 15 years of experience, specializing in innovative medical device launches, to his role with Laminate. As Head of US Sales, Kent is responsible for launching the VasQ device in the US and continuing to drive its commercial strategy in alignment with US commercial goals and Laminate’s mission to create a new standard of care for surgical fistula creation in order to improve patient outcomes for clinicians and their patients in a population who desperately need it. Before joining Laminate, Kent excelled in several medical device startups, including device launches while at ConMed Advanced Surgical, Vapotherm, and BrainScope, where he gained extensive first-hand experience overcoming the unique challenges and opportunities necessary to launch pioneering devices and technologies within healthcare systems. His expertise, combined with his personal passion to do work that matters, while making a positive difference in patients’ lives, makes him a valuable leader within the Laminate Executive team.

Gil leads our Global-OUS Sales team, overseeing Laminate’s sales channel management and strategic market expansion. He joined Laminate in February 2024, bringing over 15 years of experience in sales and business development across both the Hi-Tech and Med-Tech industries. Before joining Laminate, Gil was the Director of Global Sales at Eitan Medical, an infusion and digital health solutions provider, where he managed revenue and growth in the EMEA and APAC regions. He began his career in Tech SaaS start-ups. Gil holds an LLB in law from the Hebrew University of Jerusalem, with a specialization in corporate law and economics.